Arcutis Biotherapeutics appoints Chris Peetz to board effective July 15, 2026

The company said Peetz brings experience in biopharmaceutical growth, product development and strategic acquisitions as it adds him to its Board of Directors.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.